SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
PFE (Pfizer) How high will it go?
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
9523 158 0 PFE
Emcee:  Lynn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
8873In the U.K., it was a win on one of two patents and a loss on the other. (Hence DewDiligence_on_SI-11/9/2005
8872It's a win which is appealed - eomQualified Opinion-11/9/2005
8871<i>U.K. is a win</i> OK, we’ll call it an overtime win on penalty sDewDiligence_on_SI-11/9/2005
8870U.K. is a win. - eomQualified Opinion-11/9/2005
8869That makes 1 win (Norway), 1 loss (Austria), and 1 tie (U.K.) for PFE’s Lipitor DewDiligence_on_SI-11/9/2005
8868Pfizer Prevails in Norwegian Lipitor Patent Challenge link: biz.yahoo.comQualified Opinion-11/9/2005
8867Pfizer CEO sees Celebrex rebound Link: washingtonpost.comQualified Opinion-11/8/2005
8866New Pfizer Drug Helps Intestinal Cancer Patients - Study Edited Press ReleaseQualified Opinion-11/3/2005
8865Insider purchase, link: secfilings.nasdaq.comQualified Opinion-10/31/2005
8864Pfizer and sanofi-aventis Statement on Status of Exubera Friday October 28, 11:5Qualified Opinion-10/29/2005
8863Viagra May Treat Heart Failure By Steven Reinberg HealthDay Reporter MONDAY, Qualified Opinion-10/24/2005
8862<i>The best brand in pharma trading at an approx. 10-year low. PFE will reDewDiligence_on_SI-10/23/2005
8861<<Purchased a little today near the close, at $23.86. Hopefully, PFE will CFA-10/23/2005
8860Per the earnings CC, Pfizer's salesmen are selling Celebrex again, with a neQualified Opinion-10/23/2005
8859Wall Street Analysts seem to be a little upset by CEO's treatment of them: Wes-10/23/2005
8858Exubera (Inhaled Insulin) Information: Excerpt: The need for daily repeat injecQualified Opinion-10/22/2005
8857Pfizer's Lyrica Now Available for Patients Wednesday September 21, 8:30 am EQualified Opinion-10/22/2005
8856Pfizer Takes Cancer By Storm Matthew Herper, 05.16.05, 12:00 PM ET By This AuQualified Opinion-10/22/2005
8855Varenicline and Smoke Away For millions of individuals, the desire to stop smokQualified Opinion-10/22/2005
8854This is becoming comical. I usually wait for this scenario to develop in the oveQualified Opinion-10/21/2005
8853Update on PFE’s great plaque hope… yahoo.reuters.com >> <b> PfizerDewDiligence_on_SI-10/20/2005
8852Agreed—irresponsible headline. The second version of the newswire fixed it in paDewDiligence_on_SI-10/20/2005
8851That headline is inappropriate. It should read that PFE beat consensus estimatesQualified Opinion-10/20/2005
8850Pfizer's Net Drops 52%, Hurt by Drug-Patent Loss A WALL STREET JOURNAL ONLIDoc Bones-10/20/2005
8849Gaps are usually filled. I took advantage of the gap filling today.Qualified Opinion-10/13/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News